AREV Life Sciences Global Management
Management criteria checks 1/4
AREV Life Sciences Global's CEO is Mike Withrow, appointed in Oct 2018, has a tenure of 6.92 years. directly owns 43.44% of the company’s shares, worth CA$1.24M. The average tenure of the management team and the board of directors is 3.8 years and 2.5 years respectively.
Key information
Mike Withrow
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5yrs |
| CEO ownership | 43.4% |
| Management average tenure | 3.8yrs |
| Board average tenure | 2.5yrs |
Recent management updates
CEO
Mike Withrow
5yrs
Tenure
Mr. Michael Withrow, also known as Mike, serves as Director at AREV Life Sciences Global Corp. (formerly known as AREV NanoTec Brands Inc.) (formerly known as AREV Brands International Ltd.) (formerly, ARE...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 5yrs | no data | 43.44% CA$ 1.2m | |
| Interim CFO | 3.8yrs | CA$72.00k | 1.15% CA$ 33.0k | |
| Vice President of Marketing | 2.8yrs | no data | no data |
3.8yrs
Average Tenure
Experienced Management: AREV's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 6.9yrs | no data | 43.44% CA$ 1.2m | |
| Interim CFO | 3.8yrs | CA$72.00k | 1.15% CA$ 33.0k | |
| Director | 2.7yrs | CA$18.24k | no data | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Chairman of Scientific Advisory Board | 2.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Director | 1.8yrs | no data | 2.42% CA$ 69.1k | |
| Director | 1.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.2yrs | no data | no data |
2.5yrs
Average Tenure
Experienced Board: AREV's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/16 05:01 |
| End of Day Share Price | 2023/07/20 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AREV Life Sciences Global Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|